Semafore Pharmaceuticals
Pioneering the future of cancer treatment with innovative PI3K inhibitors.
est. 2000
Semafore Pharmaceuticals is the older company (2000 vs 2018).
Side-by-Side Comparison
| Metric | Semafore Pharmaceuticals | TRIO Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2018 |
| Headquarters | ||
| Headquarters | Not tracked yet | San Diego, United States |
| Employees | ||
| Employees | Not tracked yet | 10 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Seed |
| Total Funding | ||
| Total Funding | $13.50M | $6.83M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Not tracked yet | Development of novel dual targeting antibody drugs, Advancement of cancer immunotherapeutics, Biopharmaceutical contract development and manufacturing services |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients failing to respond to current treatments, Healthcare providers and oncology specialists, Biotech and pharma companies seeking innovative cancer treatments |
| Taxonomy | ||
| Taxonomy | Semafore Pharmaceuticals, PI3K Inhibitors, Cancer Treatment, Drug Development, Cellular Signaling Pathways, Anti-cancer Medications, Tumor Treatment, Brain Cancer, Lung Cancer, Hematological Cancer, Development-stage Company, Drug Discovery, Cancer Research, Oncology, Innovation | Cancer Therapeutics, Drug Discovery, Cancer Drug Development, Dual-Action Treatments, Immunogenic Tumors, San Diego, California, Drug Efficacy, Toxicity Reduction, Affordable Cancer Treatment, Innovative Cancer Drugs, Resistance To Immune Checkpoint Treatments, Tumor Growth Inhibition, Immunosuppression, Cancer Drug Innovation |
| Website | ||
| Website | semaforepharma.com | triopharmaceuticals.com |
About Semafore Pharmaceuticals
Semafore Pharmaceuticals is a biotechnology company founded in 2000 with the slogan "Pioneering the future of cancer treatment with innovative PI3K inhibitors." The company focuses on developing drugs that target the PI3K cellular signaling pathways to create anti-cancer medications. Their specializ...
About TRIO Pharmaceuticals, Inc.
TRIO Pharmaceuticals, Inc., founded in 2018 and headquartered in the United States, is revolutionizing cancer treatment with its innovative slogan: "Outsmart Cancer." The company is pioneering a new approach in the biotechnology and healthcare sectors by developing single-agent dual-action treatmen...
We will tell you when either one moves
BounceWatch watches Semafore Pharmaceuticals and TRIO Pharmaceuticals, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Semafore Pharmaceutica... and TRIO Pharmaceuticals,... — by email.
Frequently Asked Questions
Compare Semafore Pharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Semafore Pharmaceuticals on 26 Jul 2024, and TRIO Pharmaceuticals, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
